Lv4
510 积分 2023-11-29 加入
Safety and Monitoring of the Treatment with Disease-Modifying Therapies (DMTs) for Multiple Sclerosis (MS)
2个月前
已完结
儿童神经肌肉病的疾病修正治疗
3个月前
已完结
Phlegmonous gastritis: Review of the pathophysiology
3个月前
已关闭
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
4个月前
已完结
Diagnosis and treatment of chronic urticaria: current status and future prospects
4个月前
已完结
Sintilimab plus chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer with disease progression after EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): second interim analysis from a double-blind, randomised, placebo-controlled, phase 3 trial
4个月前
已完结
中文版慢性荨麻疹生活质量问卷（CU-Q2oL）信效度验证
5个月前
已完结
Biologic therapy for chronic spontaneous urticaria in pediatrics and adolescents: current landscape, challenges, and future perspectives
5个月前
已完结
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
5个月前
已完结
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer
5个月前
已完结
皖公网安备34019202002308
